Literature DB >> 14565589

Inflammatory mediators as essential elements in bone remodeling.

S R Goldring1.   

Abstract

Inflammatory disorders such as rheumatoid arthritis (RA), may have profound effects on skeletal homeostasis. In contrast to physiologic remodeling in which mechanical influences and/or systemic endocrine hormones initiate the remodeling process, in disorders such as RA the recruitment of macrophage lineage cells to sites of inflammation and the action of local osteoclastogenic cytokines associated with the inflammatory process initiate the remodeling process. In both physiologic and pathologic remodeling, osteoclasts appear to be the principal cell type responsible for the bone resorption. In addition, many of the same cytokines and mediators are involved in physiologic and pathologic bone remodeling. These observations have important implications with respect to the development of therapeutic strategies to prevent bone loss in inflammatory conditions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14565589     DOI: 10.1007/s00223-002-1049-y

Source DB:  PubMed          Journal:  Calcif Tissue Int        ISSN: 0171-967X            Impact factor:   4.333


  26 in total

Review 1.  [Bone metabolism: molecular mechanisms].

Authors:  E Neumann; G Schett
Journal:  Z Rheumatol       Date:  2007-07       Impact factor: 1.372

2.  Inflammatory responses improve with milk ribonuclease-enriched lactoferrin supplementation in postmenopausal women.

Authors:  Satish Bharadwaj; Tezus A G Naidu; Guru V Betageri; Nemani V Prasadarao; A Satyanarayan Naidu
Journal:  Inflamm Res       Date:  2010-05-15       Impact factor: 4.575

Review 3.  Proinflammatory cytokines and osteoporosis.

Authors:  Robert R McLean
Journal:  Curr Osteoporos Rep       Date:  2009-12       Impact factor: 5.096

Review 4.  [Fibroblastic modulators of bone destruction].

Authors:  B Dankbar; T Pap
Journal:  Z Rheumatol       Date:  2016-08       Impact factor: 1.372

5.  Differences in gene expression between the otic capsule and other bones.

Authors:  Konstantina M Stankovic; Osamu Adachi; Kunikazu Tsuji; Arthur G Kristiansen; Joe C Adams; Vicki Rosen; Michael J McKenna
Journal:  Hear Res       Date:  2010-02-08       Impact factor: 3.208

6.  Ubiquitin ligase Smurf1 mediates tumor necrosis factor-induced systemic bone loss by promoting proteasomal degradation of bone morphogenetic signaling proteins.

Authors:  Ruolin Guo; Motozo Yamashita; Qian Zhang; Quan Zhou; Di Chen; David G Reynolds; Hani A Awad; Laura Yanoso; Lan Zhao; Edward M Schwarz; Ying E Zhang; Brendan F Boyce; Lianping Xing
Journal:  J Biol Chem       Date:  2008-06-19       Impact factor: 5.157

Review 7.  T cell replicative senescence in human aging.

Authors:  Jennifer P Chou; Rita B Effros
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

8.  Serum from children with polyarticular juvenile idiopathic arthritis (pJIA) inhibits differentiation, mineralization and may increase apoptosis of human osteoblasts "in vitro".

Authors:  Valéria F Caparbo; Flávia Prada; Clóvis A A Silva; Paula L Regio; Rosa M R Pereira
Journal:  Clin Rheumatol       Date:  2008-08-07       Impact factor: 2.980

9.  Mechanisms of bone fragility in a mouse model of glucocorticoid-treated rheumatoid arthritis: implications for insufficiency fracture risk.

Authors:  Masahiko Takahata; Jason R Maher; Subhash C Juneja; Jason Inzana; Lianping Xing; Edward M Schwarz; Andrew J Berger; Hani A Awad
Journal:  Arthritis Rheum       Date:  2012-11

10.  Myostatin is a direct regulator of osteoclast differentiation and its inhibition reduces inflammatory joint destruction in mice.

Authors:  Berno Dankbar; Michelle Fennen; Daniela Brunert; Silvia Hayer; Svetlana Frank; Corinna Wehmeyer; Denise Beckmann; Peter Paruzel; Jessica Bertrand; Kurt Redlich; Christina Koers-Wunrau; Athanasios Stratis; Adelheid Korb-Pap; Thomas Pap
Journal:  Nat Med       Date:  2015-08-03       Impact factor: 53.440

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.